VYCO Stock Overview
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Vycor Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.084 |
| 52 Week High | US$0.097 |
| 52 Week Low | US$0.042 |
| Beta | 0.47 |
| 1 Month Change | -9.68% |
| 3 Month Change | 1.82% |
| 1 Year Change | n/a |
| 3 Year Change | -50.53% |
| 5 Year Change | -49.50% |
| Change since IPO | -99.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| VYCO | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -4.1% | -3.7% |
| 1Y | n/a | -2.2% | 20.5% |
Return vs Industry: Insufficient data to determine how VYCO performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how VYCO performed against the US Market.
Price Volatility
| VYCO volatility | |
|---|---|
| VYCO Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: VYCO's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine VYCO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 6 | Peter Zachariou | www.vycormedical.com |
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries.
Vycor Medical, Inc. Fundamentals Summary
| VYCO fundamental statistics | |
|---|---|
| Market cap | US$2.74m |
| Earnings (TTM) | -US$387.45k |
| Revenue (TTM) | US$1.46m |
1.9x
P/S Ratio-7.1x
P/E RatioIs VYCO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VYCO income statement (TTM) | |
|---|---|
| Revenue | US$1.46m |
| Cost of Revenue | US$144.95k |
| Gross Profit | US$1.32m |
| Other Expenses | US$1.70m |
| Earnings | -US$387.45k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | 90.08% |
| Net Profit Margin | -26.53% |
| Debt/Equity Ratio | -29.0% |
How did VYCO perform over the long term?
See historical performance and comparison